ALPMF (Astellas Pharma) Dividend Payout Ratio: 1.63 (As of Mar. 2026) — 186% Above Median


ALPMF Astellas Pharma Inc ALPMF
73 GF Score
Price $14.20
GF Value $14.67
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Astellas Pharma Dividend Payout Ratio?

Astellas Pharma ALPMF +10.51% 73 Dividend Payout Ratio is 1.63 as of Mar. 2026, which is 186% above its 10-year median of 0.57. GuruFocus rates ALPMF with a GF Score™ of 73/100 and a GF Value™ of $14.67 (Fairly Valued). The stock has 4 warning signs investors should review. Among 444 Drug Manufacturers companies, Astellas Pharma ranks worse than 65.77% on this metric.

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Astellas Pharma's Dividend Payout Ratio for the months ended in Mar. 2026 was 1.63.

The historical rank and industry rank for Astellas Pharma's Dividend Payout Ratio or its related term are showing as below:

ALPMF' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.33   Med: 0.57   Max: 12.12
Current: 0.48

During the past 13 years, the highest Dividend Payout Ratio of Astellas Pharma was 12.12. The lowest was 0.33. And the median was 0.57.

ALPMF's Dividend Payout Ratio is ranked worse than
65.77% of 444 companies
in the Drug Manufacturers industry
Industry Median: 0.375 vs ALPMF: 0.48

As of today (2026-06-28), the Dividend Yield % of Astellas Pharma is 3.48%.

During the past 13 years, the highest Trailing Annual Dividend Yield of Astellas Pharma was 5.83%. The lowest was 1.82%. And the median was 2.49%.

Astellas Pharma's Dividends per Share for the months ended in Mar. 2026 was $0.25.

During the past 12 months, Astellas Pharma's average Dividends Per Share Growth Rate was 5.40% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 9.10% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 13.50% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 10.20% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Astellas Pharma was 52.50% per year. The lowest was 1.30% per year. And the median was 7.60% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Astellas Pharma (OTCPK:ALPMF) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Astellas Pharma Dividend Payout Ratio Related Terms

Astellas Pharma Dividend Payout Ratio Historical Data

* Premium members only.

The historical data trend for Astellas Pharma's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Astellas Pharma Dividend Payout Ratio Chart

Astellas Pharma Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.88 1.11 11.97 2.67 0.49

Astellas Pharma Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.89 0.00 0.89 0.00 1.63

ALPMF vs LLY, JNJ, ABBV: Dividend Payout Ratio Comparison

For the Drug Manufacturers - General subindustry, Astellas Pharma's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Astellas Pharma Dividend Payout Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Astellas Pharma's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Astellas Pharma's Dividend Payout Ratio falls into.


ALPMF
73GF Score
Astellas Pharma Inc ALPMF
Dividend Payout Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Astellas Pharma Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

Astellas Pharma's Dividend Payout Ratio for the fiscal year that ended in Mar. 2026 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Mar. 2026 )/ EPS without NRI (A: Mar. 2026 )
=0.492/ 1.01
=0.49

Astellas Pharma's Dividend Payout Ratio for the quarter that ended in Mar. 2026 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Mar. 2026 )/ EPS without NRI (Q: Mar. 2026 )
=0.246/ 0.151
=1.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Dividend Payout Ratio →
What does a Dividend Payout Ratio of 1.63 mean?
Astellas Pharma (ALPMF) has a Dividend Payout Ratio of 1.63 as of Mar. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Astellas Pharma and its competitors. This is 186% above median its historical median of 0.57. Over the past decade, Astellas Pharma's Dividend Payout Ratio has ranged from 0.33 to 12.12. According to the industry distribution chart, Astellas Pharma ranks #292 out of 444 companies in the Drug Manufacturers industry, placing it in the top 65.8%.
Is Astellas Pharma's Dividend Payout Ratio too high?
Astellas Pharma's current Dividend Payout Ratio of 1.63 is 186% above median its 10-year median of 0.57. Over the past 10 years, this metric has ranged from a low of 0.33 to a high of 12.12. The Drug Manufacturers industry median Dividend Payout Ratio is 0.38. Astellas Pharma's value of 1.63 is 334.7% above this industry median. Based on the distribution chart, Astellas Pharma ranks #292 out of 444 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Astellas Pharma has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Astellas Pharma's Dividend Payout Ratio compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Astellas Pharma ranks #292 out of 444 companies for Dividend Payout Ratio. This places Astellas Pharma in the lower half of its industry. The industry median Dividend Payout Ratio is 0.38. Astellas Pharma's value of 1.63 is 334.7% above this benchmark. Historically, Astellas Pharma's own Dividend Payout Ratio has ranged from 0.33 to 12.12 over the past decade. While the company's 10-year median is 0.57 vs. the industry median of 0.38, Astellas Pharma has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Drug Manufacturers company?
The median Dividend Payout Ratio among Drug Manufacturers companies is 0.38, based on 444 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Astellas Pharma's current Dividend Payout Ratio of 1.63 is 334.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Astellas Pharma and its competitors. For the Drug Manufacturers industry, the median Dividend Payout Ratio is 0.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Astellas Pharma's current Dividend Payout Ratio is 1.63, which is 186% above median its own 10-year median of 0.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Astellas Pharma stock overvalued right now?
Based on GuruFocus' analysis, Astellas Pharma (ALPMF) is currently considered Fairly Valued. The stock's GF Value™ is $14.67, compared to a current price of $14.20 — trading 3.2% below its estimated fair value. The current Dividend Payout Ratio is 1.63, which is 186% above median its 10-year median of 0.57 and 334.7% above the Drug Manufacturers industry median of 0.38. Astellas Pharma's overall GF Score™ is 73/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Astellas Pharma (ALPMF), the current Dividend Payout Ratio is 1.63 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Astellas Pharma (ALPMF) Overvalued in 2026?

Based on GuruFocus' analysis, Astellas Pharma stock appears to be undervalued. The current stock price of $14.20 is trading 3.2% below its estimated GF Value™ of $14.67. GuruFocus considers Astellas Pharma to be Fairly Valued.

Key valuation signals for ALPMF:

  • Dividend Payout Ratio: 1.63 (186% above median its 10-year median of 0.57)
  • GF Value™: $14.67 vs. price of $14.20 (3.2% below fair value)
  • GF Score™: 73/100 with 4 warning signs
  • Industry Position: 334.7% above the Drug Manufacturers median (#292 of 444)

No single metric tells the full story. See the ALPMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Astellas Pharma Business Description

Address 2-5-1 Nihonbashi-Honcho, Chuo-ku, Tokyo, JPN, 103-8411
Astellas Pharma Inc is a specialty international pharmaceutical company. The company focuses on accelerating the discovery, development, and commercialization of ground-breaking innovations that could redefine expectations of care for difficult-to-treat diseases. The group is committed to driving innovation in immuno-oncology, gene therapy, mitochondria, blindness and regeneration, and targeted protein degradation. Its core products include anticancer agents like XTANDI, XOSPATA, and PADCEV; VEOZAH for the treatment of vasomotor symptoms due to menopause; Betanis / Myrbetriq / BETMIGA for the treatment of overactive bladder (OAB); and Prograf, an immunosuppressant for organ transplantation.
73GF Score

Get the complete analysis for ALPMF

Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$14.20
Price
$14.67
GF Value